Parallel deterioration of albuminuria, arterial stiffness and left ventricular mass in essential hypertension: Integrating target organ damage

Nephron - Clinical Practice

Volumn 119, Issue 1, 2011, Pages

  Andrikou, Eirini ^a   Tsioufis, Costas ^a,e   Dimitriadis, Kyriakos ^a   Flessas, Dimitrios ^a   Chatzistamatiou, Vagelis ^a   Grassos, Charalampos ^b   Papavasiliou, Maria ^c   Papadopoulos, Dimitris ^d   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Western Attica General Hospital   (Greece)

^c SISMANOGLEIO GENERAL HOSPITAL   (Greece)

^d LAIKO GENERAL HOSPITAL   (Greece)

^e NONE   (Greece)

Author keywords

Albuminuria; Arterial stiffness; Hypertension; Left ventricular mass

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMIN CREATININE RATIO; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENERAL CONDITION DETERIORATION; GROUPS BY AGE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE WAVE; RENAL SYSTEM PARAMETERS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 79957937227     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000324215     Document Type: Article

References (38)

1. Ruilope LM, Schmieder RE: Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008; 21: 500-508. (Pubitemid 351589672)
2. Fagard RH, Celis H, Thijs L, Wouters S: Regression of left ventricular mass by antihypertensive treatment: A meta-analysis of randomized comparative studies. Hypertension 2009; 54: 1084-1091.
3. Gosse P: Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 2005; 23:S27-S33. (Pubitemid 40646461)
4. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch- Johnsen K, Ibsen H: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertens 2002; 20: 405-412. (Pubitemid 34913739)
5. Falqui V, Viazzi F, Leoncini G, Ratto E, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R: Blood pressure load, vascular permeability and target organ damage in primary hypertension. J Nephrol 2007; 20(suppl 12):63-67.
6. Salmasi AM, Jepson E, Grenfell A, Kirollos C, Dancy M: The degree of albuminuria is related to left ventricular hypertrophy in hypertensive diabetics and is associated with abnormal left ventricular filling: A pilot study. Angiology 2003; 54: 671-678. (Pubitemid 37463264)
7. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, Leoncini G, Del Sette M, Brunelli C, Tomolillo C, Deferrari G: Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17: 993-1000. (Pubitemid 29322188)
8. Tsioufis C, Stefanadis C, Toutouza M, Kallikazaros I, Toutouzas K, Tousoulis D, Pitsavos C, Papademetriou V, Toutouzas P: Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects. J Hum Hypertens 2002; 16: 249-254. (Pubitemid 34441160)
9. Wiinberg N, Bang LE, Wachtell K, Larsen J, Olsen MH, Tuxen C, Hildebrandt PR, Rokkedal J, Ibsen H, Devereux RB: 24-Hour ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: Left ventricular geometry and urinary albumin excretion - a LIFE substudy. J Hum Hypertens 2004; 18: 391-396. (Pubitemid 38787033)
10. Watabe D, Hashimoto J, Hatanaka R, Hanazawa T, Ohba H, Ohkubo T, Kikuya M, Totsune K, Imai Y: Electrocardiographic left ventricular hypertrophy and arterial stiffness: The Ohasama study. Am J Hypertens 2006; 19: 1199-1205. (Pubitemid 44856245)
11. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struij ker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A: Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158.
12. Tsioufis C, Dimitriadis K, Antoniadis D, Stefanadis C, Kallikazaros I: Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens 2004; 17: 470-476. (Pubitemid 38529972)
13. Tsioufis C, Dimitriadis K, Stefanadis C, Kallikazaros I: The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: Focus on microalbuminuria. Hellenic J Cardiol 2006; 47: 361-365. (Pubitemid 47621121)
14. Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V, Toutouzas P, Stefanadis C, Kallikazaros I: Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946-951. (Pubitemid 41362518)
15. Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I: Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD40 ligand in male essential hypertensive subjects. Am J Hypertens 2006; 19: 462-466. (Pubitemid 44389665)
16. Tsioufis C, Tzioumis C, Marinakis N, Toutouzas K, Tousoulis D, Kallikazaros I, Stefanadis C, Toutouzas P: Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clin Pract 2003; 93: 106-111.
17. Tsioufis C, Dimitriadis K, Thomopoulos C, Tsiachris D, Selima M, Stefanadi E, Tousoulis D, Kallikazaros I, Stefanadis C: Exercise blood pressure response, albuminuria, and arterial stiffness in hypertension. Am J Med 2008; 121: 894-902.
18. Mulé G, Cottone S, Vadalá A, Volpe V, Mezzatesta G, Mongioví R, Piazza G, Nardi E, Andronico G, Cerasola G: Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004; 256: 22-29. (Pubitemid 38813616)
19. Zieman SJ, Melenovsky V, Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943. (Pubitemid 40627836)
20. Laurent S, Boutoyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241. (Pubitemid 34163575)
21. Tsioufis C, Tsiachris D, Dimitriadis K, Chartzoulakis G, Selima M, Chatzis D, Taxiarchou E, Stefanadis C, Kallikazaros I: Evidence for no global effect of metabolic syndrome per se on early hypertensive sequelae. J Hypertens 2008; 26: 773-779. (Pubitemid 351354926)
22. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
23. Tsioufis C, Stefanadis C, Antoniadis D, Kallikazaros I, Zambaras P, Pitsavos C, Tsiamis E, Toutouzas P: Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects. J Hum Hypertens 2000; 14: 813-818. (Pubitemid 32015834)
24. Schiller NB, Shah PM, Crawford M, De- Maria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
25. Schiller NB: Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84: 1280-1287.
26. Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, Tousoulis D, Stefanadis C, Kallikazaros I: Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 2007; 28: 1162-1169. (Pubitemid 47343887)
27. Dell'omo G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R: Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men. J Intern Med 2003; 254: 76-84. (Pubitemid 36819132)
28. Ibsen H, Olsen MH, Wachtell K, Borch- Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198-202. (Pubitemid 40179960)
29. Safar ME, Levy BI, Struijker-Boudier H: Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869. (Pubitemid 36705999)
30. Schillaci G, Mannarino M, Pucci G, Pirro M, Helou J, Savarese G, Vaudo G, Mannarino E: Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension. Hypertension 2007; 49: 317-321. (Pubitemid 46143007)
31. Girerd X, Laurent S, Pannier B, Asmar R, Safar M: Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J 1991; 122: 1210-1214.
32. Wang MC, Tsai WC, Chen JY, Cheng MF, Huang JJ: Arterial stiffness correlated with cardiac remodelling in patients with chronic kidney disease. Nephrology (Carlton) 2007; 12: 591-597.
33. Nitta K, Akiba T, Uchida K, Otsubo S, Otsubo Y, Takei T, Ogawa T, Yumura W, Kabaya T, Nihei H: Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 2004; 27: 47-52. (Pubitemid 38208421)
34. Hashimoto J, Watabe D, Hatanaka R, Otsubo S, Otsubo Y, Takei T, Ogawa T, Yumura W, Kabaya T, Nihei H: Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy. Am J Hypertens 2006; 19: 27-32. (Pubitemid 43217030)
35. Grassi G, Diez J: Obesity-related cardiac and vascular structural alterations: Beyond blood pressure overload. J Hypertens 2009; 27: 1750-1752.
36. Tsioufis C, Stougiannos P, Kakkavas A, Toutouza M, Mariolis A, Vlasseros I, Stefanadis C, Kallikazaros I: Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Am J Cardiol 2005; 96: 252-256. (Pubitemid 40978584)
37. Verdecchia P, Schillaci G, Borgioni C, Giucci A, Pede S, Porcellati C: Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-988. (Pubitemid 29001424)
38. Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C: Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: A Greek 6-year-follow- up study. J Hypertens 2009; 27: 744-752.